Treatment outcomes in localized prostate cancer: A patient-oriented approach

Seminars in Urologic Oncology

Volumn 20, Issue 1, 2002, Pages 63-73

  Lee, Richard ^a,b   Penson, David F ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Clinical decision making; Prostate cancer; Quality of life

Indexed keywords

BRACHYTHERAPY; CANCER SURVIVAL; DAILY LIFE ACTIVITY; HUMAN; INTESTINE FUNCTION DISORDER; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; SEXUAL DYSFUNCTION; SYMPTOMATOLOGY; TREATMENT OUTCOME; URINARY DYSFUNCTION;

EID: 0036172069     PISSN: 10810943     EISSN: None     Source Type: Journal    
DOI: 10.1053/suro.2002.30400     Document Type: Review

References (62)

1. Radiation therapy versus radical prostatectomy in the PSA era: A urologist's view
2. How older patients' treatment preferences are influenced by disclosures about therapeutic uncertainty: Surgery versus expectant management for localized prostate cancer
3. Patients' interpretations of probability terms
4. Assessment of endpoints for clinical trials for localized prostate cancer
5. Waning sexual function - The most important disease-specific distress for patients with prostate cancer
6. Older patients willingness to trade off urologic adverse outcomes for a better chance at five-year survival in the clinical setting of prostate cancer
7. Sex or survival: Trade offs between quality and quantity of life
8. Assessing health-related quality of life for clinical decision-making
9. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: Results of the CaPSURE database
10. Treatment decisions for localized prostate cancer: Asking men what's important
11. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The prostate cancer outcomes study
12. Multicenter patient selfreporting questionnaire on impotence, incontinence and stricture after radical prostectomy
13. Quality of life and treatment outcomes: Prostate carcinoma patients' perspectives after prostatectomy or radiation therapy
14. Quality of life of incontinent men after radical prostatectomy
15. Quality of life and continence assessment of the artificial urinary sphincter in men with minimum 3.5 years of follow-up
16. The artificial urinary sphincter for post-radical prostatectomy incontinence: Impact on urinary symptoms and quality of life
17. Sexuality after treatment for early prostate cancer: Exploring the meanings of "erectile dysfunction."
18. Prevalence and impact of incontinence and impotence following total prostatectomy assessed anonymously by the ICS-male questionnaire
19. Effect of radical prostatectomy for prostate cancer on patient quality of life: Results from a Medicare survey
20. Quality-of-life outcomes in men treated for localized prostate cancer
21. Impotence following radical prostatectomy: Insight into etiology and prevention
22. Radical retropubic prostatectomy: Morbidity and quality of life. Experience with 620 consecutive cases
23. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies
24. Patient-reported symptoms after primary therapy for early prostate cancer: Results of a prospective cohort study
25. Changes in healthrelated quality of life in the first year after treatment for prostate cancer: Results from CaPSURE
26. Role of Viagra after radical prostatectomy
27. Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra)
28. Quality of life and sexuality following radical prostatectomy in patients with prostate cancer who use or do not use erectile aids
29. The effect of hospiral volume on mortality and resource use after radical prostatectomy
30. Self-assessed healthrelated quality of life in men being treated for prostate cancer with radiotherapy: Instrument validation and its relation to patient-assessed bother of symptoms
31. Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population
32. Assessment of quality of life after radical radiotherapy for prostate cancer
33. Late effects of radiation therapy for prostate carcinoma: The patient's perspective of bladder, bowel and sexual morbidity
34. Late side effects unchanged 4-8 years after radiotherapy for prostate carcinoma: A comparison with age-matched controls
35. Urinary function and bother after radical prostatectomy or radiation for prostate cancer: A longitudinal, multivariate quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor
36. Potency preservation following conformal radiotherapy for localized prostate cancer: Impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors
37. Outcomes of externalbeam radiation therapy for prostate cancer: A study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas
38. Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life
39. Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate
40. Quality of life: Radical prostatectomy versus radiation therapy for prostate cancer
41. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: The patient's perspective
42. Quality of life after permanent prostate implant
43. Temporal resolution of urinary morbidity following prostate brachytherapy
44. A prospective analysis of patient-reported quality of life after prostate brachytherapy
45. Long-term treatment related complications of brachytherapy for early prostate cancer: A survey of patients previously treated
46. Is brachytherapy comparable with radical prostatectomy and external-beam radiation for clinically localized prostate cancer?
47. Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer
48. Quality of life outcomes after brachytherapy for early stage prostate cancer
49. Health-related quality of life and sequelae in patients treated with brachytherapy and external beam irradiation for localized prostate cancer
50. The wild, wild Web: Resources for counseling patients with prostate cancer in the information age
51. What questions do patients with curable prostate cancer want answered?
52. Healthcare 2000
53. The use of videobased patient education for shared decision-making in the treatment of prostate cancer
54. Perils, pitfalls, and possibilities in talking about medical risk
55. Patients' interpretations of verbal expressions of probability: Implications for securing informed consent to medical interventions
56. How age, outcome severity, and scale influence general medicine clinic patients' interpretations of verbal probability terms
57. General performance on a numeracy scale among highly educated samples
58. The role of risk and benefit perception in informed consent for surgery
59. Perception of quantitative information for treatment decisions
60. Patients' and physicians' interpretations of graphic data displays
61. Patient preferences: Survival vs quality-of-life considerations